Sirolimus Use in Angioplasty for Vascular Access Extension (SAVE)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by Lawson Health Research Institute
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
Anthony Jevnikar, Lawson Health Research Institute
ClinicalTrials.gov Identifier:
NCT01595841
First received: May 2, 2012
Last updated: September 8, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)